NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.

Patiromer

Last Revision: December 3, 2018.

CASRN: 1260643-52-4

Chemical structure

Drug Levels and Effects

Summary of Use during Lactation

Because patiromer is not orally absorbed it is unlikely to reach the breastmilk or adversely affect the breastfed infant. No special precautions are required.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Sodium Polystyrene Sulfonate

Substance Identification

Substance Name

Patiromer

CAS Registry Number

1260643-52-4

Drug Class

  • Breast Feeding
  • Lactation
  • Cation Exchange Resins
  • Chelating Agents

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Copyright Notice

Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.

Bookshelf ID: NBK500756PMID: 29999815
Contents